Email Alert | RSS    帮助

中国防痨杂志 ›› 2014, Vol. 36 ›› Issue (11): 958-965.doi: 10.3969/j.issn.1000-6621.2014.11.008

• 论著 • 上一篇    下一篇

基因测序检测embB基因诊断结核分枝杆菌乙胺丁醇耐药性的Meta分析

程松 李园园 胡忠义 崔振玲   

  1. 200433 同济大学附属上海市肺科医院 上海市结核病(肺)重点实验室
  • 收稿日期:2014-06-18 出版日期:2014-11-10 发布日期:2014-12-05
  • 通信作者: 崔振玲 E-mail:cuizhenling@163.com
  • 基金资助:

    国家自然科学基金(81201323);国家“十二五”重大科技专项(2013ZX10003001-003)

The diagnostic value of PCR-DNA sequencing for the rapid detection of ethambutol-resistance in Mycobacterium tuberculosis: a Meta-analysis

CHENG Song, LI Yuan-yuan, HU Zhong-yi, CUI Zhen-ling   

  1. Shanghai Tuberculosis Key Laboratory,the Pulmonary Hospital of Shanghai Affiliated Tongji University, Shanghai 200433, China
  • Received:2014-06-18 Online:2014-11-10 Published:2014-12-05
  • Contact: CUI Zhen-ling E-mail:cuizhenling@163.com

摘要: 目的 采用Meta分析的方法评价基因测序快速诊断结核分枝杆菌(Mtb)对乙胺丁醇耐药性的诊断价值。方法 检索PubMed、Web Of Science、OVID、Cochrane Library、中国知网、万方和维普等数据库,初步检索文献767篇,剔除重复后获得566篇文献,通过阅读题目及摘要初步排除477篇,其余89篇文献进入全文筛选,最终纳入18篇。根据诊断试验系统评价质量评价工具QUADAS-2(quality assessment of diagnostic accuracy stu-dies)标准评价文献,通过Q检验进行文献异质性分析,运用Meta-Disc 1.4软件计算总敏感度、总特异度、诊断优势比等统计量。结果 基因测序检测embB306位点,检测embB306、embB406位点,检测embB306、embB406、embB497位点突变诊断结核分枝杆菌乙胺丁醇耐药性的总敏感度(95%可信区间,95%CI)分别为0.56(0.53~0.59)、0.60(0.56~0.64)、0.76(0.70~0.81),总特异度(95%CI)分别为0.93(0.92~0.94)、0.89(0.86~0.91)、0.89(0.83~0.93);诊断优势比(95%CI)分别为17.59(9.35~33.10)、15.24(5.51~42.11)、33.69(4.53~250.90)。结论 基因测序检测embB306、embB406、embB497位点诊断结核分枝杆菌乙胺丁醇耐药性总特异度较高,可作为早期快速耐药株检测的初筛方法。

关键词: 分枝杆菌, 结核, 乙胺丁醇, 抗药性, 细菌, 戊糖基转移酶类, Meta分析

Abstract: Objective Using a Meta-analysis to evaluate the diagnostic value of PCR-DNA sequencing for the detection of embB gene mutations in Mycobacterium tuberculosisMethods The relevant studies were searched in PubMed, Web of Science, OVID, Cochrane library, China National Knowledge Infrastructure (CNKI), Wanfang and Weipu datebase. At first, 767 citations were identified from all researches, 566 studies were obtained after excluding duplicate citations, 477 studies were preliminarily excluded by reading the titles and abstracts of all studies,and the residual 89 were included into screening full text, 18 independent studies were included at last. QUADAS-2 (quality assessment of diagnostic accuracy studies) was used to assess the quality of included studies, heterogeneity was analyzed using Q tests. Using Meta-Disc (version 1.4) to count statistical measures including pooled sensitivity, pooled specificity, diagnostic odds ratio (DOR), etc.. Results The pooled sensitivities (95% confidence interval (CI)) of PCR-DNA sequencing for detecting the mutations of embB306 codon, combination of embB306 and 406 codons, and combination of embB306, 406 and 497 codons were 0.56 (0.53-0.59), 0.60 (0.56-0.64), 0.76 (0.70-0.81), respectively. Their pooled specificities (95%CI) were 0.93 (0.92-0.94),0.89 (0.86-0.91), 0.89 (0.83-0.93), respectively. The DOR were 17.59 (9.35-33.10), 15.24 (5.51-42.11), 33.69 (4.53-250.90), respectively.  Conclusion The summarized specificity of PCR-DNA sequencing for detecting the mutations of embB 306,406,497 codons in Mycobacterium tuberculosis was high, and it was appropriate choice for detecting drug resistance to ethambutol.

Key words: Mycobacterium tuberculosis, Ethambutol, Drug resistance, bacterial, Pentosyltransferases, Meta-analysis